Clinicology Ltd.
Registered name: CLINICOLOGY LTD.
Clinicology Ltd. made £1.4m revenue and £79.1k profit in the year to 31 Dec 2025.
Clinicology Ltd.’s revenue was £1.4m in the year to 31 Dec 2025, with £79.1k profit and 7 employees. The company is classified under “research and experimental development on biotechnology” and is based in Guildford; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Guildford, South East
- Age
- 15 yrs · since 2011
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “FGK Clinical Research GmbH”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Oct 2022 | 31 Oct 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | Profit only | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £1.1m | £1.4m |
| Cost of sales | — | — | £587k | £931k |
| Gross profit | — | — | £524k | £484k |
| Operating profit | — | — | £40.3k | £97.6k |
| Profit before tax | — | — | £50k | £104k |
| Profit after tax | — | £295k | £24.5k | £79.1k |
| Profit (best available) | — | £295k | £24.5k | £79.1k |
| Employees (average) | 4 | 6 | 7 | 7 |
| Ratios | ||||
| Profit margin | — | — | 2.2% | 5.6% |
| Gross margin | — | — | 47.2% | 34.2% |
| Revenue per employee | — | — | £159k | £202k |
| Profit per employee | — | £49.2k | £3.5k | £11.3k |
| Growth (year on year) | ||||
| Headcount growth | — | ▲50% | — | — |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £284k | £959k | £372k | £497k |
| Net assets | £399k | £363k | £384k | £463k |
| Fixed assets | £68.3k | £82.2k | £15.5k | £10.5k |
| Current assets | £526k | £1.4m | £531k | £561k |
| Debtors | £226k | £331k | £46.8k | £18.2k |
| Deferred income | £52.3k | £350k | £23.8k | £21.3k |
| Source | Accounts · bulk data Dec 2023 | Accounts · bulk data Dec 2023 | FullAccounts · bulk data Jun 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 5.6%
- Profit ÷ revenue.
- Gross margin
- 34.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £202k
- Revenue ÷ average employees.
- Profit per employee
- £11.3k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.7%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 1.5%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 1.3%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now £463k
- Cash at bank
- —
- Now £497k
- Headcount
- —
- Now 7
- Deferred income
- —
- Now £21.3k
- Fixed assets
- —
- Now £10.5k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Adorx Therapeutics LimitedEdinburgh · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £211k
- Staff
- 0
- Nuritas UK LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £88.8k
- Staff
- 4
- Collaborative Community Against Coronavirus CICLondon · Research and experimental development on biotechnology
- Revenue
- £786k
- Profit
- £29.9k
- Staff
- 0
- Takara Bio UK LtdLondon · Research and experimental development on biotechnology
- Revenue
- £3.1m
- Profit
- £97.2k
- Staff
- 9
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £79.1k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Updated from Companies House on 15 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.